Resveratrol as a natural anti-tumor necrosis factor-a molecule: Implications to dendritic cells and their crosstalk with mesenchymal stromal cells

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Silva, Andreia M ^a,b   Oliveira, Marta I ^a   Sette, Laura ^a   Almeida, Catarina R ^a   Oliveira, Maria J ^a,b,c   Barbosa, Mário A ^a,b   Santos, Susana G ^a  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; ENZYME PRECURSOR; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; MATRIX METALLOPROTEINASE; RESVERATROL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STILBENE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BUFFY COAT; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL MOTILITY; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TIME LAPSE IMAGING; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY; ANTAGONISTS AND INHIBITORS; CELL DEATH; CELL MOTION; CELL NUCLEUS; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; INFLAMMATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHENOTYPE; PROTEIN TRANSPORT; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

CELL DEATH; CELL DIFFERENTIATION; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; HUMANS; INFLAMMATION; MESENCHYMAL STROMAL CELLS; NF-KAPPA B; PHENOTYPE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897542839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091406     Document Type: Article

References (48)

1. Schildknecht A, Brauer S, Brenner C, Lahl K, Schild H, et al. (2010) FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells. Proc Natl Acad Sci USA 107: 199-203.
2. Garbi N, Hammerling GJ, Probst HC, van den Broek M (2010) Tonic T cell signalling and T cell tolerance as opposite effects of self-recognition on dendritic cells. Curr Opin Immunol 22: 601-608.
3. Miwa S, Nishida H, Tanzawa Y, Takata M, Takeuchi A, et al. (2012) TNF-alpha and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors. PLoS One 7: e52926.
4. Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka AK (2003) TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol 171: 2262-2269. (Pubitemid 37028309)
5. Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, et al. (2005) Anti-TNF therapy: where have we got to in 2005? J Autoimmun 25 Suppl: 26-28. (Pubitemid 41728040)
6. Jongbloed SL, Lebre MC, Fraser AR, Gracie JA, Sturrock RD, et al. (2006) Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res Ther 8: R15.
7. Hacquard-Bouder C, Chimenti MS, Giquel B, Donnadieu E, Fert I, et al. (2007) Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: Selective impairment of costimulatory molecule engagement by mature HLA-B27. Arthritis Rheum 56: 1478-1489. (Pubitemid 46764076)
8. Hacquard-Bouder C, Falgarone G, Bosquet A, Smaoui F, Monnet D, et al. (2004) Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy. Arthritis Rheum 50: 1624-1635. (Pubitemid 38608085)
9. Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B (2007) Effects of resveratrol in inflammatory arthritis. Inflammation 30: 1-6. (Pubitemid 46438042)
10. Elmali N, Esenkaya I, Harma A, Ertem K, Turkoz Y, et al. (2005) Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res 54: 158-162. (Pubitemid 41178921)
11. Okada Y, Oh-oka K, Nakamura Y, Ishimaru K, Matsuoka S, et al. (2012) Dietary resveratrol prevents the development of food allergy in mice. PLoS One 7: e44338.
12. Leiro JM, Varela M, Piazzon MC, Arranz JA, Noya M, et al. (2010) The anti-inflammatory activity of the polyphenol resveratrol may be partially related to inhibition of tumour necrosis factor-alpha (TNF-alpha) pre-mRNA splicing. Mol Immunol 47: 1114-1120.
13. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, et al. (2006) Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 291: H1694-1699. (Pubitemid 44497674)
14. Deng YH, Alex D, Huang HQ, Wang N, Yu N, et al. (2011) Inhibition of TNF-alpha-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3, 5, 49-trimethoxystilbene. Phyt-other Res 25: 451-457.
15. Lee B, Moon SK (2005) Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells. J Nutr 135: 2767-2773. (Pubitemid 43156539)
16. Svajger U, Obermajer N, Jeras M (2010) Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology 129: 525-535.
17. Singer NG, Caplan AI (2011) Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6: 457-478.
18. Almeida CR, Vasconcelos DP, Goncalves RM, Barbosa MA (2012) Enhanced mesenchymal stromal cell recruitment via natural killer cells by incorporation of inflammatory signals in biomaterials. J R Soc Interface 9: 261-271.
19. Oliveira MI, Santos SG, Oliveira MJ, Torres AL, Barbosa MA (2012) Chitosan drives anti-inflammatory macrophage polarisation and pro-inflammatory dendritic cell stimulation. Eur Cell Mater 24: 136-152; discussion 152-133.
20. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. Journal of Experimental Medicine 179: 1109-1118.
21. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, et al. (1997) Differentiation of human dendritic cells from monocytes in vitro. European Journal of Immunology 27: 431-441. (Pubitemid 27085247)
22. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, et al. (1997) Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. The Journal of Immunology 158: 2919-2925. (Pubitemid 127470554)
23. Santos S, Lynch S, Campbell E, Antoniou A, Powis S (2008) Induction of HLA-B27 heavy chain homodimer formation after activation in dendritic cells. Arthritis Research & Therapy 10: R100.
24. Mangi RJ, Kantor FS (1975) The multiple mixed lymphocyte reaction: variables important in the test as a measure of lymphocyte competence in man. Yale Journal of Biology and Medicine 48: 217-228.
25. Scheinecker C, Machold KP, Majdic O, Höcker P, Knapp W, et al. (1998) Initiation of the Autologous Mixed Lymphocyte Reaction Requires the Expression of Costimulatory Molecules B7-1 and B7-2 on Human Peripheral Blood Dendritic Cells. The Journal of Immunology 161: 3966-3973. (Pubitemid 28468973)
26. Manna SK, Mukhopadhyay A, Aggarwal BB (2000) Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519. (Pubitemid 30408836)
27. Ryu J, Ku BM, Lee YK, Jeong JY, Kang S, et al. (2011) Resveratrol reduces TNF-alpha-induced U373MG human glioma cell invasion through regulating NF-kappaB activation and uPA/uPAR expression. Anticancer Res 31: 4223-4230.
28. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. (Pubitemid 44269669)
29. Bertelli AA, Baccalini R, Battaglia E, Falchi M, Ferrero ME (2001) Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie 56: 613-616. (Pubitemid 34027039)
30. Bi XL, Yang JY, Dong YX, Wang JM, Cui YH, et al. (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 5: 185-193. (Pubitemid 39626704)
31. Zhu J, Yong W, Wu X, Yu Y, Lv J, et al. (2008) Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun 369: 471-477.
32. Kim GY, Cho H, Ahn SC, Oh YH, Lee CM, et al. (2004) Resveratrol inhibits phenotypic and functional maturation of murine bone marrow-derived dendritic cells. Int Immunopharmacol 4: 245-253. (Pubitemid 38296353)
33. Gu X, Creasy L, Kester A, Zeece M (1999) Capillary electrophoretic determination of resveratrol in wines. J Agric Food Chem 47: 3223-3227. (Pubitemid 29422018)
34. Poulsen MM, Jorgensen JO, Jessen N, Richelsen B, Pedersen SB (2013) Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann N Y Acad Sci 1290: 74-82.
35. Augustin MA, Sanguansri L, Lockett T (2013) Nano-and micro-encapsulated systems for enhancing the delivery of resveratrol. Ann N Y Acad Sci 1290: 107-112.
36. Neves AR, Lucio M, Lima JL, Reis S (2012) Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 19: 1663-1681.
37. Dai Z, Li Y, Quarles LD, Song T, Pan W, et al. (2007) Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine 14: 806-814. (Pubitemid 350017876)
38. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, et al. (2009) Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59: 330-337.
39. Kundu JK, Chun KS, Kim SO, Surh YJ (2004) Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets. Biofactors 21: 33-39. (Pubitemid 40921823)
40. Kim YA, Choi BT, Lee YT, Park DI, Rhee SH, et al. (2004) Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep 11: 441-446.
41. Abrams MB, Dominguez C, Pernold K, Reger R, Wiesenfeld-Hallin Z, et al. (2009) Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor Neurol Neurosci 27: 307-321.
42. Bouffi C, Djouad F, Mathieu M, Noel D, Jorgensen C (2009) Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology (Oxford) 48: 1185-1189.
43. Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D (2010) Immunosup-pression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 1: 2.
44. Spaggiari GM, Moretta L (2013) Cellular and molecular interactions of mesenchymal stem cells in innate immunity. Immunol Cell Biol 91: 27-31.
45. Fu X, Han B, Cai S, Lei Y, Sun T, et al. (2009) Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen 17: 185-191.
46. Bocker W, Docheva D, Prall WC, Egea V, Pappou E, et al. (2008) IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesen-chymal stem cells. J Mol Med (Berl) 86: 1183-1192.
47. Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, et al. (2009) In vitro study of matrix metalloproteinase/tissue inhibitor of metallopro-teinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 11: 559-569.
48. Woo JH, Lim JH, Kim YH, Suh SI, Min DS, et al. (2004) Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853. (Pubitemid 38445410)